Multicentre experience using daclatasvir and sofosbuvir to treat hepatitis C recurrence – The ANRS CUPILT study

Overview of attention for article published in Journal of Hepatology, June 2016

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (89th percentile)
Above-average Attention Score compared to outputs of the same age and source (64th percentile)

Mentioned by

twitter: 18 X users
facebook: 1 Facebook page

guideline: 2 clinical guideline sources

Readers on

mendeley: 67 Mendeley

So far, Altmetric has seen 25 X posts from 18 X users, with an upper bound of 54,519 followers.

Multicentre experience using daclatasvir and sofosbuvir to treat hepatitis C recurrence — The ANRS CUPILT study https://t.co/R3Fxi2anaK

RT @JHepatology: New drug combination cures #HCV recurrence in #liver #transplant patients https://t.co/hY7mNcJYSu #LTx #HepC

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 21 additional X posts.